Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The neuropathology of genetic Parkinson's disease.

Identifieur interne : 000E23 ( PubMed/Curation ); précédent : 000E22; suivant : 000E24

The neuropathology of genetic Parkinson's disease.

Auteurs : Markos Poulopoulos [États-Unis] ; Oren A. Levy ; Roy N. Alcalay

Source :

RBID : pubmed:22451330

English descriptors

Abstract

Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRRK2, and glucocerebrosidase have accumulated in recent years. The aim of this review is to systematically review all pathological reports of mutation carriers and to identify pathological patterns and gaps in the currently available data. A systematic review of the English literature was done using the terms "Parkinson's disease," "brain pathology," "autopsy," the specific gene nomenclature, and any combination of the above. Most studies included reports of convenience samples: either cases that were preidentified as mutation carriers before autopsy or screens of Lewy body brain banks. Nineteen autopsies of alpha-synuclein mutation carriers, 49 of LRRK2 mutation carriers, nine of Parkin mutation carriers, one of a PINK1 mutation carrier, and 86 of glucocerebrosidase mutation carriers were identified. Most autopsies of alpha-synuclein, LRRK2 G2019S, and glucocerebrosidase mutation carriers demonstrated Lewy body pathology, as opposed to Parkin and LRRK2 non-G2019S mutation carriers. However, there was a marked variability in pathological findings, even among carriers of identical mutations. Pathological data from DJ1 mutation carriers, nonmanifesting mutation carriers (e.g., of LRRK2 mutations), and carriers of a single Parkin mutation were lacking. In gathering together all studies of PD autopsies with an identified genetic risk, this review highlights the wealth of information generated as well as shortcomings in the available data. In particular, there is a need for larger, unbiased pathological studies. Differential association of Lewy pathology with specific mutations may reflect heterogeneity in pathogenic mechanisms among the different PD-related genes.

DOI: 10.1002/mds.24962
PubMed: 22451330

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22451330

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The neuropathology of genetic Parkinson's disease.</title>
<author>
<name sortKey="Poulopoulos, Markos" sort="Poulopoulos, Markos" uniqKey="Poulopoulos M" first="Markos" last="Poulopoulos">Markos Poulopoulos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Levy, Oren A" sort="Levy, Oren A" uniqKey="Levy O" first="Oren A" last="Levy">Oren A. Levy</name>
</author>
<author>
<name sortKey="Alcalay, Roy N" sort="Alcalay, Roy N" uniqKey="Alcalay R" first="Roy N" last="Alcalay">Roy N. Alcalay</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1002/mds.24962</idno>
<idno type="RBID">pubmed:22451330</idno>
<idno type="pmid">22451330</idno>
<idno type="wicri:Area/PubMed/Corpus">000E23</idno>
<idno type="wicri:Area/PubMed/Curation">000E23</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The neuropathology of genetic Parkinson's disease.</title>
<author>
<name sortKey="Poulopoulos, Markos" sort="Poulopoulos, Markos" uniqKey="Poulopoulos M" first="Markos" last="Poulopoulos">Markos Poulopoulos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Levy, Oren A" sort="Levy, Oren A" uniqKey="Levy O" first="Oren A" last="Levy">Oren A. Levy</name>
</author>
<author>
<name sortKey="Alcalay, Roy N" sort="Alcalay, Roy N" uniqKey="Alcalay R" first="Roy N" last="Alcalay">Roy N. Alcalay</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Brain (pathology)</term>
<term>Genetic Predisposition to Disease (genetics)</term>
<term>Humans</term>
<term>Mutation (genetics)</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (pathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Genetic Predisposition to Disease</term>
<term>Mutation</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRRK2, and glucocerebrosidase have accumulated in recent years. The aim of this review is to systematically review all pathological reports of mutation carriers and to identify pathological patterns and gaps in the currently available data. A systematic review of the English literature was done using the terms "Parkinson's disease," "brain pathology," "autopsy," the specific gene nomenclature, and any combination of the above. Most studies included reports of convenience samples: either cases that were preidentified as mutation carriers before autopsy or screens of Lewy body brain banks. Nineteen autopsies of alpha-synuclein mutation carriers, 49 of LRRK2 mutation carriers, nine of Parkin mutation carriers, one of a PINK1 mutation carrier, and 86 of glucocerebrosidase mutation carriers were identified. Most autopsies of alpha-synuclein, LRRK2 G2019S, and glucocerebrosidase mutation carriers demonstrated Lewy body pathology, as opposed to Parkin and LRRK2 non-G2019S mutation carriers. However, there was a marked variability in pathological findings, even among carriers of identical mutations. Pathological data from DJ1 mutation carriers, nonmanifesting mutation carriers (e.g., of LRRK2 mutations), and carriers of a single Parkin mutation were lacking. In gathering together all studies of PD autopsies with an identified genetic risk, this review highlights the wealth of information generated as well as shortcomings in the available data. In particular, there is a need for larger, unbiased pathological studies. Differential association of Lewy pathology with specific mutations may reflect heterogeneity in pathogenic mechanisms among the different PD-related genes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22451330</PMID>
<DateCreated>
<Year>2012</Year>
<Month>06</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>27</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2012</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>The neuropathology of genetic Parkinson's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>831-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.24962</ELocationID>
<Abstract>
<AbstractText>Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRRK2, and glucocerebrosidase have accumulated in recent years. The aim of this review is to systematically review all pathological reports of mutation carriers and to identify pathological patterns and gaps in the currently available data. A systematic review of the English literature was done using the terms "Parkinson's disease," "brain pathology," "autopsy," the specific gene nomenclature, and any combination of the above. Most studies included reports of convenience samples: either cases that were preidentified as mutation carriers before autopsy or screens of Lewy body brain banks. Nineteen autopsies of alpha-synuclein mutation carriers, 49 of LRRK2 mutation carriers, nine of Parkin mutation carriers, one of a PINK1 mutation carrier, and 86 of glucocerebrosidase mutation carriers were identified. Most autopsies of alpha-synuclein, LRRK2 G2019S, and glucocerebrosidase mutation carriers demonstrated Lewy body pathology, as opposed to Parkin and LRRK2 non-G2019S mutation carriers. However, there was a marked variability in pathological findings, even among carriers of identical mutations. Pathological data from DJ1 mutation carriers, nonmanifesting mutation carriers (e.g., of LRRK2 mutations), and carriers of a single Parkin mutation were lacking. In gathering together all studies of PD autopsies with an identified genetic risk, this review highlights the wealth of information generated as well as shortcomings in the available data. In particular, there is a need for larger, unbiased pathological studies. Differential association of Lewy pathology with specific mutations may reflect heterogeneity in pathogenic mechanisms among the different PD-related genes.</AbstractText>
<CopyrightInformation>Copyright © 2012 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Poulopoulos</LastName>
<ForeName>Markos</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Levy</LastName>
<ForeName>Oren A</ForeName>
<Initials>OA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Alcalay</LastName>
<ForeName>Roy N</ForeName>
<Initials>RN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K08 NS070608</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08 NS070608-01</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K08NS070608</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12 RR017648</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K12 RR017648-01</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR024156</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR024156-01</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>03</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Genet Metab. 2003 Jun;79(2):104-9</RefSource>
<PMID Version="1">12809640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2003 Aug;54(2):176-85</RefSource>
<PMID Version="1">12891670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2003 Oct 31;302(5646):841</RefSource>
<PMID Version="1">14593171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Genet Metab. 2004 Jan;81(1):70-3</RefSource>
<PMID Version="1">14728994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2004 Feb;55(2):164-73</RefSource>
<PMID Version="1">14755719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2004 Feb;55(2):174-9</RefSource>
<PMID Version="1">14755720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Genet. 2004 Mar;41(3):e22</RefSource>
<PMID Version="1">14985393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 May 11;62(9):1619-22</RefSource>
<PMID Version="1">15136696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Genet Metab. 2004 Jul;82(3):192-207</RefSource>
<PMID Version="1">15234332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 Aug 24;63(4):678-82</RefSource>
<PMID Version="1">15326242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71</RefSource>
<PMID Version="1">15451225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1990 Mar;27(3):276-82</RefSource>
<PMID Version="1">2158268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 1991;82(4):239-59</RefSource>
<PMID Version="1">1759558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</RefSource>
<PMID Version="1">1564476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neural Transm Suppl. 1993;39:165-72</RefSource>
<PMID Version="1">8360656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1994 Jan;35(1):59-64</RefSource>
<PMID Version="1">8285594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1994 Mar;44(3 Pt 1):437-41</RefSource>
<PMID Version="1">8145912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1996 Jul;47(1):160-6</RefSource>
<PMID Version="1">8710071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 1997 Mar;60(3):588-96</RefSource>
<PMID Version="1">9042918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1997 Jun 27;276(5321):2045-7</RefSource>
<PMID Version="1">9197268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Neurol. 1997;38 Suppl 1:39-43</RefSource>
<PMID Version="1">9276200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 1998 Feb;18(2):106-8</RefSource>
<PMID Version="1">9462735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1998 Jun;43(6):768-81</RefSource>
<PMID Version="1">9629847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 1998 Aug;96(2):207-10</RefSource>
<PMID Version="1">9705138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1998 Sep;51(3):890-2</RefSource>
<PMID Version="1">9748052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 1999 Jul 30;270(2):110-2</RefSource>
<PMID Version="1">10462110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Nov 18;44(4):601-7</RefSource>
<PMID Version="1">15541309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2004 Dec;61(12):1898-904</RefSource>
<PMID Version="1">15596610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2005 Jan;20(1):100-3</RefSource>
<PMID Version="1">15517591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2005 Jan 29-Feb 4;365(9457):415-6</RefSource>
<PMID Version="1">15680457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Feb 17;352(7):728-31; author reply 728-31</RefSource>
<PMID Version="1">15716572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2005 Sep;58(3):411-22</RefSource>
<PMID Version="1">16130111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2005 Nov;58(5):803-7</RefSource>
<PMID Version="1">16240358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2005 Dec;128(Pt 12):2786-96</RefSource>
<PMID Version="1">16272164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2005 Dec 27;65(12):1863-72</RefSource>
<PMID Version="1">16237129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropathol Appl Neurobiol. 2006 Feb;32(1):23-5</RefSource>
<PMID Version="1">16409550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2006 Jan 26;354(4):424-5</RefSource>
<PMID Version="1">16436782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Feb;59(2):298-309</RefSource>
<PMID Version="1">16358335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Feb;59(2):388-93</RefSource>
<PMID Version="1">16437559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Feb;59(2):315-22</RefSource>
<PMID Version="1">16437584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2006 Mar;59(3):449-58</RefSource>
<PMID Version="1">16489609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2006 Jul;129(Pt 7):1720-31</RefSource>
<PMID Version="1">16702191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 Sep 12;67(5):908-10</RefSource>
<PMID Version="1">16790605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 Oct 24;67(8):1506-8</RefSource>
<PMID Version="1">17060589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Jan 30;68(5):326-37</RefSource>
<PMID Version="1">17261678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Jan 15;22(2):275-8</RefSource>
<PMID Version="1">17149743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Behav. 2007 Feb 28;90(2-3):506-11</RefSource>
<PMID Version="1">17174362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2007 Mar;13(2):89-92</RefSource>
<PMID Version="1">17222580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2007 May;78(5):532-5</RefSource>
<PMID Version="1">17202228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2007 May;113(5):601-6</RefSource>
<PMID Version="1">17151837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8</RefSource>
<PMID Version="1">17210620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2007 Sep;114(3):221-9</RefSource>
<PMID Version="1">17653732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Sep 18;69(12):1270-7</RefSource>
<PMID Version="1">17875915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2008 Jan 1;70(1):43-9</RefSource>
<PMID Version="1">17625105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Sep;22 Suppl 17:S343-50</RefSource>
<PMID Version="1">18175395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropathology. 2008 Feb;28(1):74-80</RefSource>
<PMID Version="1">18031467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2008 Jan 15;70(3):238-41</RefSource>
<PMID Version="1">18195271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2008 Mar;65(3):379-82</RefSource>
<PMID Version="1">18332251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2008 Apr;115(4):399-407</RefSource>
<PMID Version="1">18297293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2008 Apr;65(4):514-9</RefSource>
<PMID Version="1">18413475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mutat. 2008 May;29(5):567-83</RefSource>
<PMID Version="1">18338393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Sci. 2008 Jul 15;270(1-2):94-8</RefSource>
<PMID Version="1">18353371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2008 Jul;7(7):583-90</RefSource>
<PMID Version="1">18539534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2008 Jul;116(1):25-35</RefSource>
<PMID Version="1">18389263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2008 Sep 23;71(13):1021-6</RefSource>
<PMID Version="1">18809839</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Jan 27;72(4):310-6</RefSource>
<PMID Version="1">18987351</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2009 Jan 15;24(1):32-9</RefSource>
<PMID Version="1">19006185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2009 Mar;117(3):227-46</RefSource>
<PMID Version="1">19142648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Mar 31;72(13):1185-6</RefSource>
<PMID Version="1">19332698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2009 May;15(4):300-6</RefSource>
<PMID Version="1">18804399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2009 May;66(5):578-83</RefSource>
<PMID Version="1">19433657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 Jul;132(Pt 7):1783-94</RefSource>
<PMID Version="1">19286695</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2009 Jul;12(7):826-8</RefSource>
<PMID Version="1">19503083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2009 Jul;15(6):414-6</RefSource>
<PMID Version="1">18829375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Jul 28;73(4):279-86</RefSource>
<PMID Version="1">19636047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Dent Sci. 2008 Mar;55(1):145-53</RefSource>
<PMID Version="1">19845160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2009 Oct 15;24(13):1998-2001</RefSource>
<PMID Version="1">19735093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2010 Feb;16(2):132-5</RefSource>
<PMID Version="1">19527940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Apr;133(Pt 4):1128-42</RefSource>
<PMID Version="1">20356854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurodegener Dis. 2010;7(1-3):175-9</RefSource>
<PMID Version="1">20197701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2010 May;67(5):684-9</RefSource>
<PMID Version="1">20437567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2010 Jun;67(6):731-8</RefSource>
<PMID Version="1">20558392</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2010 Aug;120(2):155-67</RefSource>
<PMID Version="1">20232069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2010 Sep;67(9):1116-22</RefSource>
<PMID Version="1">20837857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2010 Nov;120(5):641-9</RefSource>
<PMID Version="1">20838799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2011 Jan 1;20(1):202-10</RefSource>
<PMID Version="1">20947659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2011 Jan;17(1):55-7</RefSource>
<PMID Version="1">20971030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2011 Jan 25;76(4):319-26</RefSource>
<PMID Version="1">21205674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Genet Metab. 2011 Aug;103(4):410-2</RefSource>
<PMID Version="1">21621439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Aug 15;26(10):1793-802</RefSource>
<PMID Version="1">21735483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Neurosci. 2012 May;47(1):139-43</RefSource>
<PMID Version="1">22194196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2012 May;18(4):332-8</RefSource>
<PMID Version="1">22154298</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2000 May 25;342(21):1560-7</RefSource>
<PMID Version="1">10824074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2000 Jun;99(6):663-72</RefSource>
<PMID Version="1">10867800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2000 Sep;15(5):884-8</RefSource>
<PMID Version="1">11009195</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2001 Feb 27;56(4):555-7</RefSource>
<PMID Version="1">11222808</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2001 Apr;68(4):895-900</RefSource>
<PMID Version="1">11254447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2001 Mar;49(3):313-9</RefSource>
<PMID Version="1">11261505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2001 Sep;69(3):629-34</RefSource>
<PMID Version="1">11462174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Genet Metab. 2001 Aug;73(4):313-21</RefSource>
<PMID Version="1">11509013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2001 Sep;50(3):293-300</RefSource>
<PMID Version="1">11558785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Epidemiol. 2002 Jan;55(1):25-31</RefSource>
<PMID Version="1">11781119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2002 Jul;104(1):7-11</RefSource>
<PMID Version="1">12070658</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2002 Jun 25;58(12):1791-800</RefSource>
<PMID Version="1">12084879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2002 Dec;52(6):849-53</RefSource>
<PMID Version="1">12447943</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2002 Nov;17(6):1374-80</RefSource>
<PMID Version="1">12465088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2003 Mar-Apr;24(2):197-211</RefSource>
<PMID Version="1">12498954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2003 Jan 10;299(5604):256-9</RefSource>
<PMID Version="1">12446870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropathology. 2003 Mar;23(1):90-4</RefSource>
<PMID Version="1">12722931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2003 Jun;9(5):247-51</RefSource>
<PMID Version="1">12781588</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009419">Nerve Tissue Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS361937</OtherID>
<OtherID Source="NLM">PMC3383342</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>7</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2011</Year>
<Month>12</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>2</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint">
<Year>2012</Year>
<Month>3</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/mds.24962</ArticleId>
<ArticleId IdType="pubmed">22451330</ArticleId>
<ArticleId IdType="pmc">PMC3383342</ArticleId>
<ArticleId IdType="mid">NIHMS361937</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E23 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000E23 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22451330
   |texte=   The neuropathology of genetic Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22451330" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024